Development and In vivo Pharmacokinetic and Pharmacodynamic Evaluation of an Oral Innovative Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan Formulation for Enhanced Bioavailability
Nanotheranostics · 2023 · 7 (1) · 117-127
DOI: 10.7150/ntno.78102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanotheranostics, 2023. Verfasst von Narendar Dudhipala und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Vaagdevi Pharmacy College, Warangal, Telangana, India - 506005. Hauptthemen laut MEDLINE: Cyclodextrins, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Vaagdevi Pharmacy College, Warangal, Telangana, India - 506005.
- Synapse Life Sciences, Warangal, Telangana, India - 506001.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, 33516, Egypt.
Zitieren
APA
Dudhipala, N., Ettireddy, S., Youssef, A. A. A., & Puchchakayala, G. (2023). Development and In vivo Pharmacokinetic and Pharmacodynamic Evaluation of an Oral Innovative Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan Formulation for Enhanced Bioavailability. Nanotheranostics, 7(1), 117-127. https://doi.org/10.7150/ntno.78102
Vancouver
Dudhipala N, Ettireddy S, Youssef AAA, Puchchakayala G. Development and In vivo Pharmacokinetic and Pharmacodynamic Evaluation of an Oral Innovative Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan Formulation for Enhanced Bioavailability. Nanotheranostics. 2023;7(1):117-127. doi:10.7150/ntno.78102
BibTeX
@article{Dudhipala2023,
author = {Dudhipala, Narendar and Ettireddy, Swetha and Youssef, Ahmed Adel Ali and Puchchakayala, Goverdhan},
title = {Development and In vivo Pharmacokinetic and Pharmacodynamic Evaluation of an Oral Innovative Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan Formulation for Enhanced Bioavailability},
journal = {Nanotheranostics},
year = {2023},
volume = {7},
number = {1},
pages = {117--127},
doi = {10.7150/ntno.78102}
}
EUVIMED